Enanta Pharmaceuticals, Inc. Gains 91.9%
Mon, Sep 29, 2025 at 08:24 PM
Enanta Pharmaceuticals, Inc. (ENTA:NASDAQ) soared at $15.16, a gain of 91.9%. On Mon, Sep 29, 2025, ENTA:NASDAQ hit a New 2-Week High of $15.16. The stock got featured on our News Catalysts scanner on Mon, Sep 29, 2025 at 10:30 AM in the 'BIOTECH' category. From Mon, Sep 15, 2025, the stock recorded 60.00% Up Days and 63.64% Green Days
About Enanta Pharmaceuticals, Inc. (ENTA:NASDAQ)
Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Group uses its chemistry-driven approach & drug discovery capabilities to develop its products.
Top 10 Gainers:
- Wolfspeed, Inc. (WOLF:NYSE), 1726.45%
- Boqii Holding Limited (BQ:NYSEMKT), 233.22%
- cbdMD, Inc. (YCBD:NYSEMKT), 121.15%
- Enanta Pharmaceuticals, Inc. (ENTA:NASDAQ), 91.9%
- JFB Construction Holdings (JFB:NASDAQ), 85.4%
- Tilray Brands, Inc. (TLRY:NASDAQ), 60.87%
- Predictive Oncology Inc. (POAI:NASDAQ), 54.82%
- SRAX, Inc. (SRAX:NASDAQ), 50%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- Steakholder Foods Ltd. (STKH:NASDAQ), 46.03%